Evidence map›Paper›PMID 37895021›Full record

ArticleInternational journal of molecular sciences2023

Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis.

Federica Mescia, Shaghayegh Bayati, Elisabeth Brouwer, Peter Heeringa, Erik J M Toonen, Marijke Beenes, Miriam J Ball, Andrew J Rees, Renate Kain, Paul A Lyons and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Special Issue "Deployment of Proteomics Approaches in Biomedical Research".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Federica MesciaDepartment of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.ORCID 0000-0002-2759-4027
Shaghayegh BayatiDepartment of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.
Elisabeth BrouwerDepartment of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Peter HeeringaDepartment of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0001-8684-763X
Erik J M ToonenR&D Department, Hycult Biotech, 5405 PB Uden, The Netherlands.ORCID 0000-0001-9039-635X
Marijke BeenesR&D Department, Hycult Biotech, 5405 PB Uden, The Netherlands.
Miriam J BallDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Andrew J ReesDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Renate KainDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-2428-543X
Paul A LyonsDepartment of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.ORCID 0000-0001-7035-8997
Peter NilssonDepartment of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.ORCID 0000-0002-4657-8532
Elisa PinDepartment of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.ORCID 0000-0002-2158-2674
Medical University of Vienna · ATScience for Life Laboratory · SEHycult Biotech (Netherlands) · NLUniversity Medical Center Groningen · NLUniversity of Cambridge · GB

Funding

Marie Curie 813545
6 · The paper itself

Abstract

ANCA-associated vasculitides (AAV) are rare autoimmune diseases causing inflammation and damage to small blood vessels. New autoantibody biomarkers are needed to improve the diagnosis and treatment of AAV patients. In this study, we aimed to profile the autoantibody repertoire of AAV patients using in-house developed antigen arrays to identify previously unreported antibodies linked to the disease per se, clinical subgroups, or clinical activity. A total of 1743 protein fragments representing 1561 unique proteins were screened in 229 serum samples collected from 137 AAV patients at presentation, remission, and relapse. Additionally, serum samples from healthy individuals and patients with other type of vasculitis and autoimmune-inflammatory conditions were included to evaluate the specificity of the autoantibodies identified in AAV. Autoreactivity against members of the kinesin protein family were identified in AAV patients, healthy volunteers, and disease controls. Anti-KIF4A antibodies were significantly more prevalent in AAV. We also observed possible associations between anti-kinesin antibodies and clinically relevant features within AAV patients. Further verification studies will be needed to confirm these findings.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAutoantibodiesBiomarkersHumansKinesinsProteinsAutoantibodiesBiomarkersKinesinsProteinsANCA-associated vasculitisautoantibody profilingbiomarkerskinesinsprotein array

Identifiers

PMID37895021
PMCPMC10607136
OpenAlexW4387776076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.